Cancer News and Stories
Our team of experts brings you cancer-related news, features, and survivor stories.
For the latest news about research we conduct and fund, see ACS Research News.
Filtering by:
Lung Cancer
Who Should Be Screened for Lung Cancer?
Published on: October 14, 2020
A harsh truth about lung cancer is that it doesn’t usually cause symptoms until the cancer has spread, which makes difficult to treat. That’s why the idea of screening – looking for lung cancer in people who do not have any symptoms – is appealing.
Lung Cancer Risks for People Who Don't Smoke
Published on: October 14, 2020
About 20% of people who die from lung cancer in the United States every year have never smoked or used any form of tobacco. Here’s what we know about why some people who don't smoke get lung cancer.
Mesothelioma Survivor Lives Life Every Day
Published on: November 25, 2019
It’s been more than 7 years since Ward was diagnosed with pleural mesothelioma, a type of cancer that starts in the lining of the chest. The main risk factor is breathing in asbestos, often in workplaces such as mines. But Ward spent her career as a nurse working in hospitals and doctors’ offices.
How to Test Your Home for Radon
Published on: October 21, 2019
Radon is a key cause of lung cancer, and it could be lurking undetected in your home. Testing is easy and inexpensive, and it could help protect you and your family.
FDA Approves Tecentriq (Atezolizumab) for Small Cell Lung Cancer
Published on: March 19, 2019
The US Food and Drug Administration (FDA) has approved the immunotherapy drug Tecentriq (atezolizumab) for the treatment of small cell lung cancer (SCLC).
Lung Cancer Screening Guideline: Frequently Asked Questions
Published on: January 24, 2019
The American Cancer Society lung cancer screening guidelines recommend yearly low dose CT (LDCT) for certain people at higher risk of lung cancer that meet several conditions.
Lung Cancer Screening Guidelines for Current or Former Smokers
Published on: January 24, 2019
American Cancer Society guidelines recommend yearly lung cancer screening for people who meet certain criteria that put them at higher risk for developing the disease.
FDA Approves Vitrakvi (Larotrectinib) for Tumors With Certain Genetic Change
Published on: November 28, 2018
For the second time, the US Food and Drug Administration (FDA) has approved a drug to treat tumors with a specific genetic change regardless of the type of cancer. Vitrakvi (larotrectinib) is for adults and children with solid tumors that test positive for NTRK genes, which can help cancerous tumors grow.